Search Results - "Tsai, Hsing‐Ju"
-
1
Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[S]
Published in Journal of lipid research (01-12-2010)“…Beneficial physiological effects of long-chain n-3 polyunsaturated fatty acids are widely accepted but the mechanism(s) by which these fatty acids act remains…”
Get full text
Journal Article -
2
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance
Published in Proceedings of the National Academy of Sciences - PNAS (31-05-2011)“…Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular…”
Get full text
Journal Article -
3
Soluble epoxide hydrolase: a novel therapeutic target in stroke
Published in Journal of cerebral blood flow and metabolism (01-12-2007)“…The P450 eicosanoids epoxyeicosatrienoic acids (EETs) are produced in brain and perform important biological functions, including protection from ischemic…”
Get full text
Journal Article -
4
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
Published in British journal of pharmacology (01-01-2009)“…Background and purpose: Early soluble epoxide hydrolase inhibitors (sEHIs) such as 12‐(3‐adamantan‐1‐yl‐ureido)‐dodecanoic acid (AUDA) are effective…”
Get full text
Journal Article -
5
Prevention and Reversal of Cardiac Hypertrophy by Soluble Epoxide Hydrolase Inhibitors
Published in Proceedings of the National Academy of Sciences - PNAS (05-12-2006)“…Sustained cardiac hypertrophy represents one of the most common causes leading to cardiac failure. There is emerging evidence to implicate the involvement of…”
Get full text
Journal Article -
6
Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model
Published in Journal of cardiovascular pharmacology (01-10-2008)“…To determine whether sEH inhibitors influence atherosclerotic lesion formation, we used an established murine model of accelerated atherogenesis, ApoE knockout…”
Get full text
Journal Article -
7
Immunoassay for Monitoring Environmental and Human Exposure to the Polybrominated Diphenyl Ether BDE-47
Published in Environmental science & technology (15-10-2009)“…We developed a selective competitive enzyme-linked immunosorbent assay (ELISA) to monitor environmental and human exposure to polybrominated diphenyl ether…”
Get full text
Journal Article -
8
Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide Hydrolase
Published in The Journal of biological chemistry (26-12-2008)“…Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase…”
Get full text
Journal Article -
9
Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren‐2 transgenic rats with inducible hypertension
Published in The Journal of physiology (01-01-2011)“…Non‐technical summary Arachidonic acid metabolites called epoxyeicosatrienoic acids (EETs) influence vascular tone and renal tubular sodium and water transport…”
Get full text
Journal Article -
10
Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase
Published in American journal of physiology: endocrinology and metabolism (01-08-2009)“…Soluble epoxide hydrolase (Ephx2, sEH) is a bifunctional enzyme with COOH-terminal hydrolase and NH(2)-terminal phosphatase activities. sEH converts…”
Get more information
Journal Article -
11
Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase
Published in Bioorganic & medicinal chemistry letters (15-09-2012)“…Substituted ureas with a carboxylic acid ester as a secondary pharmacophore are potent soluble epoxide hydrolase (sEH) inhibitors. Although the ester…”
Get full text
Journal Article -
12
The Soluble Epoxide Hydrolase as a Pharmaceutical Target for Hypertension
Published in Journal of cardiovascular pharmacology (01-09-2007)Get full text
Journal Article -
13
Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation
Published in The Journal of pharmacology and experimental therapeutics (01-12-2008)“…Epoxyeicosatrienoic acids (EETs) are derived from cytochrome P450-catalyzed epoxygenation of arachidonic acid and have emerged as important mediators of…”
Get more information
Journal Article -
14
Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors
Published in Journal of medicinal chemistry (09-08-2007)“…A series of N,N‘-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepared and tested as soluble…”
Get full text
Journal Article -
15
immunoassay for a urinary metabolite as a biomarker of human exposure to the pyrethroid insecticide permethrin
Published in Analytical and bioanalytical chemistry (01-02-2006)“…Permethrin is the most popular synthetic pyrethroid insecticide used in agriculture and public health. For the assessment of human exposure to permethrin, a…”
Get full text
Journal Article -
16
Continuous low-level aquatic monitoring (CLAM) samplers for pesticide contaminant screening in urban runoff: Analytical approach and a field test case
Published in Chemosphere (Oxford) (01-10-2017)“…Monitoring of surface waters for organic contaminants is costly. Grab water sampling often results in non-detects for organic contaminants due to missing a…”
Get full text
Journal Article -
17
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Published in The American journal of pathology (01-06-2009)“…Inhibition of soluble epoxide hydrolase (SEH), the enzyme responsible for degradation of vasoactive epoxides, protects against cerebral ischemia in rats…”
Get full text
Journal Article -
18
In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors
Published in Biochemical pharmacology (15-12-2015)“…[Display omitted] N,N′-disubstituted urea-based soluble epoxide hydrolase (sEH) inhibitors are promising therapeutics for hypertension, inflammation, and pain…”
Get full text
Journal Article -
19
Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs
Published in European journal of pharmaceutical sciences (14-06-2010)“…Epoxyeicosatrienoic acids that have anti-hypertensive and anti-inflammatory properties are mainly metabolized by soluble epoxide hydrolase (sEH, EC 3.3.2.3)…”
Get full text
Journal Article -
20
1,3-Disubstituted Ureas Functionalized with Ether Groups are Potent Inhibitors of the Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties
Published in Journal of medicinal chemistry (18-10-2007)“…Soluble epoxide hydrolase (sEH) is a therapeutic target for treating hypertension and inflammation. 1,3-Disubstituted ureas functionalized with an ether group…”
Get full text
Journal Article